SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-24-011493
Filing Date
2024-03-27
Accepted
2024-03-27 16:02:02
Documents
89
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1867441
2 ex4-6.htm EX-4.6 28721
3 ex19-1.htm EX-19.1 99962
4 ex21-1.htm EX-21.1 2665
5 ex23-1.htm EX-23.1 4709
6 ex31-1.htm EX-31.1 7847
7 ex31-2.htm EX-31.2 7955
8 ex32-1.htm EX-32.1 6718
9 ex97-1.htm EX-97.1 32626
10 form10-k_001.jpg GRAPHIC 19236
11 form10-k_002.jpg GRAPHIC 36615
12 form10-k_003.jpg GRAPHIC 26591
13 form10-k_004.jpg GRAPHIC 33276
  Complete submission text file 0001493152-24-011493.txt   7352553

Data Files

Seq Description Document Type Size
14 XBRL SCHEMA FILE mtnb-20231231.xsd EX-101.SCH 42329
15 XBRL CALCULATION FILE mtnb-20231231_cal.xml EX-101.CAL 79130
16 XBRL DEFINITION FILE mtnb-20231231_def.xml EX-101.DEF 153736
17 XBRL LABEL FILE mtnb-20231231_lab.xml EX-101.LAB 371667
18 XBRL PRESENTATION FILE mtnb-20231231_pre.xml EX-101.PRE 310585
93 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 869519
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-484-8805
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38022 | Film No.: 24790517
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)